Browsing Bergen Open Research Archive by Author "Halvorsen, Sigrun"
Now showing items 1-6 of 6
-
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Wisløff, Torbjørn; Selmer, Randi M.; Halvorsen, Sigrun; Fretheim, Atle; Norheim, Ole Frithjof; Kristiansen, Ivar Sønbø (Peer reviewed; Journal article, 2012-04-04)Background: Hypertension is one of the leading causes of cardiovascular disease (CVD). A range of antihypertensive drugs exists, and their prices vary widely mainly due to patent rights. The objective of this study was to ... -
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a scandinavian population-based cohort study
Halvorsen, Sigrun; Johnsen, Søren P.; Madsen, Morten; Linder, Marie; Sulo, Gerhard; Ghanima, Waleed; Gislason, Gunnar; Hohnloser, Stefan H.; Jenkins, Aaron; Al-Khalili, Faris; Tell, Grethe S.; Ehrenstein, Vera (Journal article; Peer reviewed, 2021)Aims Using Scandinavian population-based registries, we assessed risk of stroke/systemic embolism (SE) and bleeding with non-vitamin K antagonist oral anticoagulants compared with warfarin in anticoagulation-naïve patients ... -
Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study
Fossum, Stine; Næss, Øyvind; Halvorsen, Sigrun; Tell, Grethe S.; Vikanes, Åse (Peer reviewed; Journal article, 2019-06-12)Objective: To investigate whether exposure to hyperemesis gravidarum (hyperemesis) is associated with subsequent maternal cardiovascular morbidity. Design: Nationwide cohort study. Setting: Medical Birth Registry of Norway ... -
The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial
Boskovic, Miroslav; Jortveit, Jarle; Haraldsen, Marius Blørstad; Berge, Trygve; Engdahl, Johan; Løchen, Maja-Lisa; Schuster, Peter Moritz; Sandberg, Edvard Liljedahl; Grimsmo, Jostein; Atar, Dan; Anfinsen, Ole-Gunnar; Pripp, Are Hugo; Grenne, Bjørnar Leangen; Halvorsen, Sigrun (Journal article; Peer reviewed, 2024)Aims Atrial fibrillation (AF) is a common arrhythmia, and many cases of AF may be undiagnosed. Whether screening for AF and subsequent treatment if AF is detected can improve long-term outcome remains an unsettled ... -
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
Awoyemi, Ayodeji Olawale; Mayerhofer, Cristiane; Felix, Alex S.; Hov, Johannes Espolin Roksund; Moscavitch, Samuel D.; Lappegård, Knut Tore; Hovland, Anders; Halvorsen, Sigrun; Halvorsen, Bente; Gregersen, Ida; Svardal, Asbjørn M.; Berge, Rolf Kristian; Hansen, Simen Hyll; Götz, Alexandra; Holm, Kristian; Aukrust, Pål; Åkra, Sissel; Seljeflot, Ingebjørg; Solheim, Svein; Lorenzo, Andrea; Gullestad, Lars; Trøseid, Marius; Broch, Kaspar (Journal article; Peer reviewed, 2021)Background The gut microbiota represents a potential treatment target in heart failure (HF) through microbial metabolites such as trimethylamine N-oxide (TMAO) and systemic inflammation. Treatment with the probiotic yeast ... -
Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
Stensjøen, Anne Line; Hommerstad, Anders; Halvorsen, Sigrun; Arheden, Håkan; Engblom, Henrik; Erlinge, David; Larsen, Alf Inge; Sejersten Ripa, Maria; Clemmensen, Peter; Atar, Dan; Hall, Trygve Sørdahl (Journal article; Peer reviewed, 2020)Background ECG changes after revascularization predicts improved outcome for patients with ST‐elevation myocardial infarction (STEMI). Worst lead residual (WLR) ST deviation and resolution of worst lead ST elevation (rST ...